Equities

Zhejiang Taimei Medical Technology Co Ltd

Zhejiang Taimei Medical Technology Co Ltd

Actions
  • Price (HKD)5.46
  • Today's Change-0.14 / -2.50%
  • Shares traded78.60k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,0681,4081,400
Total Receivables, Net209199156
Total Inventory------
Prepaid expenses254329
Other current assets, total259.696.67
Total current assets1,3261,6601,592
Property, plant & equipment, net4185110
Goodwill, net475578
Intangibles, net252626
Long term investments------
Note receivable - long term------
Other long term assets0----
Total assets1,4451,8251,805
LIABILITIES
Accounts payable714843
Accrued expenses120164132
Notes payable/short-term debt000
Current portion long-term debt/capital leases123237
Other current liabilities, total155147138
Total current liabilities358391350
Total long term debt2.781441
Total debt154677
Deferred income tax------
Minority interest64730
Other liabilities, total42363.28
Total liabilities466515394
SHAREHOLDERS EQUITY
Common stock538538538
Additional paid-in capital1,1301,1301,130
Retained earnings (accumulated deficit)(695)(362)(257)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total6.154.270
Total equity9781,3101,411
Total liabilities & shareholders' equity1,4451,8251,805
Total common shares outstanding560560560
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.